Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

In Medtronic’s case specifically, the EY authors write, the company reported that its ability to predict and modulate supply ...

An FDA panel unanimously rejected J&J's V-Wave Ventura heart shunt, citing risks outweighing benefits despite safety data.

This week in Pedersen's POV, MD+DI Senior Editor Amanda Pedersen explores the medtech industry's most pressing needs as 2025 ...

During the early stages of the pandemic, SPAC mergers were the route that many medtech companies took to go public.

Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.

The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...

Trelleborg opens its first Central American facility in Costa Rica, enhancing medical device production and sustainability.

Boston Scientific faces intense competition from major players such as Medtronic, Johnson & Johnson, and Abbott Laboratories.

Several notable medtech companies, including BD, Medline, and Baxter, have earned themselves a spot on FDA's November recalls ...

The Waltham, MA-based company said it now expects a full-year 2025 cash burn rate of about $45 million, down from its ...

Sade Mokulu of Watson-Marlow Fluid Technology Solutions highlights key medtech trends for 2026, including the shift toward ...